“We are very pleased to continue our commitment to BaseLaunch. Basel has always been home to great ideas and innovation and today it is a leading life sciences hub within Switzerland and globally.”

James SabryGlobal Head of Roche Pharma Partnering

“We are delighted to join BaseLaunch as a partner in the next phase of its company building activities. The Pureos team worked closely with BaseLaunch during the Series A funding of Alentis Therapeutics and has been very impressed by the team and the quality of the selected programs.”

Klaus Breiner, PhDManaging Partner at Pureos Bioventures

“In joining BaseLaunch, centered in the Basel Area, a major hub for life sciences innovation in Europe, our team is very excited to explore new opportunities of discovering promising therapeutic ventures and supporting exceptional seed-stage biotech companies developing sciences into novel therapeutics.”

James LeeCEO at Bridge Biotherapeutics

“This partnership will help us identify and build relationships with potential external collaborators from throughout Europe…”

Dr. Adrian ZuercherVice President, Research Europe and Head of Plasma Protein Research, CSL Behring

“Incubators and accelerators are central to the global healthcare start-up ecosystem. We have been collaborating with BaseLaunch since launch in supporting the growth and development of early-stage biotech ventures and recognize the contribution the team has made towards achieving their goals...”

Nerida ScottHead, Johnson & Johnson Innovation

“CMS is delighted to be part of BaseLaunch, giving us the opportunity to meet and support truly innovative companies linked to one of the preeminent centres globally for healthcare R&D.”

James StearnsCIO (Europe & Americas), China Medical System Holdings

“With our involvement in the review process and funding decisions through our investment board seat, we aim to contribute to BaseLaunch‘s company creation track record and leverage AbbVie‘s expertise in translating innovative science into novel therapeutics.”

Christian SchubertVice President and Head of AbbVie Ventures, Cambridge, MA